tiprankstipranks
Trending News
More News >
Cytek Biosciences (CTKB)
NASDAQ:CTKB
US Market

Cytek Biosciences (CTKB) Income Statement

Compare
103 Followers

Cytek Biosciences Income Statement

Last quarter (Q3 2025), Cytek Biosciences's total revenue was $52.29M, an increase of 1.54% from the same quarter last year. In Q3, Cytek Biosciences's net income was $-5.48M. See Cytek Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 200.45M$ 193.01M$ 164.04M$ 127.95M$ 92.84M
Gross Profit
$ 111.11M$ 109.43M$ 100.97M$ 79.14M$ 51.71M
Operating Expenses
$ 131.63M$ 137.27M$ 102.78M$ 69.99M$ 38.05M
Depreciation and Amortization
$ 10.49M$ 9.23M$ 5.66M$ 1.24M$ 603.00K
EBITDA
$ -10.03M$ -4.41M$ 9.49M$ 8.92M$ 15.37M
Operating Income
$ -20.52M$ -27.84M$ -1.80M$ 9.16M$ 13.66M
Other Income/Expenses
$ 14.82M$ 12.14M$ 3.06M$ -3.22M$ 771.00K
Pretax Income
$ -5.70M$ -15.71M$ 1.26M$ 5.94M$ 14.43M
Net Income
$ -6.02M$ -12.15M$ 2.58M$ 3.00M$ 19.41M
Per Share Metrics
Basic EPS
$ -0.05$ -0.09$ 0.02$ 0.03$ 0.02
Diluted EPS
$ -0.05$ -0.09$ 0.02$ 0.03$ 0.02
Weighted Average Shares Outstanding
130.61M 135.28M 134.51M 133.75M 132.99M
Weighted Average Shares Outstanding (Diluted)
130.61M 135.28M 138.56M 133.75M 132.99M
Currency in USD

Cytek Biosciences Earnings and Revenue History